search
Back to results

BAriaTric Surgery After Breast Cancer Treatment (BATS)

Primary Purpose

Early-stage Breast Cancer, Obesity

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Bariatric Surgery with Sleeve Gastrectomy
Lifestyle Intervention
Sponsored by
Masonic Cancer Center, University of Minnesota
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Early-stage Breast Cancer

Eligibility Criteria

18 Years - 67 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of breast cancer in the previous 10 years and currently disease free.
  • Completion of breast cancer treatment (radiation, chemotherapy) at least > 6 months prior to enrollment
  • Body mass index (BMI) of ≥ 35 kg/m2, but < 50 kg/m2.
  • 18 through 67 years of age at enrollment
  • Deemed healthy enough to undergo bariatric surgery, if assigned intervention, as determined by a surgeon and documented in the medical record.
  • Must have insurance coverage with no exclusion for obesity related treatment or management of obesity related surgical complications - in general insurance coverage is available for persons with a BMI ≥ 35 kg/m2.
  • Anticipated ability to abide by study requirements demonstrated in part by, but not limited to, successful completion of run-in assessments.
  • Willingness to accept randomization into either interventional group.
  • Provides voluntary written consent prior to performance of any research related activities.

Exclusion Criteria:

  • Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months.
  • Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease.
  • Cardiac stress test indicating that surgery or lifestyle would not be safe.
  • 12-lead EKG indicating that surgery would not be safe.
  • Significant anemia (hemoglobin 1.0 g/dL or more below normal range) or history of coagulopathy.
  • History of stomach surgery, bile duct surgery, pancreatic surgery, splenectomy, or colon resection.
  • Gastric or duodenal ulcer in the past six months.
  • History of intra-abdominal sepsis except for uncomplicated appendicitis or diverticulitis more than six months prior to enrollment.
  • Self-reported HIV-positive status, active tuberculosis, active malaria, chronic hepatitis B or C, cirrhosis, or inflammatory bowel disease.
  • Currently pregnant or nursing, or planning to become pregnant in the next 15 months.
  • History of alcohol, drug, or opioid dependency (excluding nicotine) in the past five years.
  • Active psychosocial or psychiatric problem that is likely to interfere with adherence to the protocol.
  • Deemed not an acceptable candidate by a trained psychologist.
  • Current participation in a conflicting research protocol.
  • Presence of any chronic or debilitating disease that would make adherence to the protocol difficult.
  • Gastroesophageal reflux disease requiring medications. History of endoscopy demonstrating esophagitis or Barrett's changes in the esophagus.
  • Any history of dysphagia.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Sleeve Gastrectomy & Lifestyle Intervention

    Lifestyle Intervention

    Arm Description

    Outcomes

    Primary Outcome Measures

    Feasibility of Weight Loss Intervention
    Feasibility for women who were diagnosed with early stage breast cancer in the previous 10 years and have a body mass index (BMI) of ≥ 35 kg/m2 but < 50 kg/m2.
    Acceptability of Weight Loss Intervention
    Acceptability of women who were diagnosed with early stage breast cancer in the previous 10 years and have a body mass index (BMI) of ≥ 35 kg/m2 but < 50 kg/m2.

    Secondary Outcome Measures

    Weight Loss
    Percent body mass weight loss
    Breast Cancer Recurrence
    Incidence of breast cancer recurrence
    Cancer Related Mortality
    Incidence of cancer related mortality
    Overall Mortality
    Incidence of overall mortality

    Full Information

    First Posted
    May 8, 2019
    Last Updated
    May 25, 2023
    Sponsor
    Masonic Cancer Center, University of Minnesota
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03946423
    Brief Title
    BAriaTric Surgery After Breast Cancer Treatment (BATS)
    Official Title
    BAriaTric Surgery After Breast Cancer Treatment (BATS) - A Randomized Trial of Sleeve Gastrectomy Versus Lifestyle Intervention in Women Diagnosed With Early Stage Breast and With a BMI of ≥ 35
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    October 2023 (Anticipated)
    Primary Completion Date
    February 2025 (Anticipated)
    Study Completion Date
    February 2025 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Masonic Cancer Center, University of Minnesota

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    This is a feasibility study to gain an understanding of the willingness of women with a history of early stage breast cancer and current obesity to enroll in a weight-loss study, accept an assigned intervention (bariatric surgery with lifestyle intervention or lifestyle intervention alone), and comply with the study plan for 1 year. If there is successful enrollment in this study, the plan is to use what is learned in this study to design a larger, longer-term clinical trial to look at the effect of weight loss and incidence of cancer recurrence.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Early-stage Breast Cancer, Obesity

    7. Study Design

    Primary Purpose
    Other
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    40 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Sleeve Gastrectomy & Lifestyle Intervention
    Arm Type
    Experimental
    Arm Title
    Lifestyle Intervention
    Arm Type
    Active Comparator
    Intervention Type
    Procedure
    Intervention Name(s)
    Bariatric Surgery with Sleeve Gastrectomy
    Intervention Description
    Standard of care bariatric surgery with sleeve gastrectomy
    Intervention Type
    Behavioral
    Intervention Name(s)
    Lifestyle Intervention
    Intervention Description
    All participants receive lifestyle intervention. The lifestyle intervention program is modeled closely after that used in the Diabetes Primary Prevention Trial and the LookAHEAD diabetes treatment studies. Intervention includes counseling sessions weekly for the first six months, twice a month during months 7-9, and monthly during months 10-12, and energy intake and exercise goal monitoring and guidance.
    Primary Outcome Measure Information:
    Title
    Feasibility of Weight Loss Intervention
    Description
    Feasibility for women who were diagnosed with early stage breast cancer in the previous 10 years and have a body mass index (BMI) of ≥ 35 kg/m2 but < 50 kg/m2.
    Time Frame
    1 Year
    Title
    Acceptability of Weight Loss Intervention
    Description
    Acceptability of women who were diagnosed with early stage breast cancer in the previous 10 years and have a body mass index (BMI) of ≥ 35 kg/m2 but < 50 kg/m2.
    Time Frame
    1 Year
    Secondary Outcome Measure Information:
    Title
    Weight Loss
    Description
    Percent body mass weight loss
    Time Frame
    1 Year
    Title
    Breast Cancer Recurrence
    Description
    Incidence of breast cancer recurrence
    Time Frame
    1 Year
    Title
    Cancer Related Mortality
    Description
    Incidence of cancer related mortality
    Time Frame
    1 Year
    Title
    Overall Mortality
    Description
    Incidence of overall mortality
    Time Frame
    1 Year

    10. Eligibility

    Sex
    Female
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    67 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Diagnosis of breast cancer in the previous 10 years and currently disease free. Completion of breast cancer treatment (radiation, chemotherapy) at least > 6 months prior to enrollment Body mass index (BMI) of ≥ 35 kg/m2, but < 50 kg/m2. 18 through 67 years of age at enrollment Deemed healthy enough to undergo bariatric surgery, if assigned intervention, as determined by a surgeon and documented in the medical record. Must have insurance coverage with no exclusion for obesity related treatment or management of obesity related surgical complications - in general insurance coverage is available for persons with a BMI ≥ 35 kg/m2. Anticipated ability to abide by study requirements demonstrated in part by, but not limited to, successful completion of run-in assessments. Willingness to accept randomization into either interventional group. Provides voluntary written consent prior to performance of any research related activities. Exclusion Criteria: Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months. Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease. Cardiac stress test indicating that surgery or lifestyle would not be safe. 12-lead EKG indicating that surgery would not be safe. Significant anemia (hemoglobin 1.0 g/dL or more below normal range) or history of coagulopathy. History of stomach surgery, bile duct surgery, pancreatic surgery, splenectomy, or colon resection. Gastric or duodenal ulcer in the past six months. History of intra-abdominal sepsis except for uncomplicated appendicitis or diverticulitis more than six months prior to enrollment. Self-reported HIV-positive status, active tuberculosis, active malaria, chronic hepatitis B or C, cirrhosis, or inflammatory bowel disease. Currently pregnant or nursing, or planning to become pregnant in the next 15 months. History of alcohol, drug, or opioid dependency (excluding nicotine) in the past five years. Active psychosocial or psychiatric problem that is likely to interfere with adherence to the protocol. Deemed not an acceptable candidate by a trained psychologist. Current participation in a conflicting research protocol. Presence of any chronic or debilitating disease that would make adherence to the protocol difficult. Gastroesophageal reflux disease requiring medications. History of endoscopy demonstrating esophagitis or Barrett's changes in the esophagus. Any history of dysphagia.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Sara Eischen
    Phone
    612-624-0902
    Email
    bengt008@umn.edu
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Anne Blaes, MD
    Organizational Affiliation
    University of Minnesota, Division of Hematology, Oncology and Transplantation
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    BAriaTric Surgery After Breast Cancer Treatment (BATS)

    We'll reach out to this number within 24 hrs